- 201. Drug Suspending Agent
- [Therapeutically inactive ingredient of pharmaceutical dosage form used to prevent aggregation of the active drug in liquid form, allowing uniform concentrations to be maintained for accurate dosing. ( NCI )] (UMLS (NCI) C0038959) =Biomedical or Dental Material
| - 217. DrugEntity
- [A substance whose therapeutic effect is produced by chemical action within the body. ( HL7V3.0 )] (UMLS (HL7) C1699392) =Intellectual Product =MaterialEntityClassType;
=ClinicalDrug |
- 202. drug synthesis
- [ ] (UMLS (CSP) C0920480) Drug Synthesis and Chemistry =Biomedical Occupation or Discipline
| - 218. Drugs primarily affecting the autonomic nervous system causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0543418) =Injury or Poisoning
|
- 203. drug test (pharmacology)
- [ ] (UMLS (CSP) C0598332) =Laboratory Procedure
| - 219. DRUGS, MEDICINAL AND BIOLOGICAL SUBSTANCES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE
- [ ] (UMLS (ICD9CM) C0178359) =Injury or Poisoning
|
- 204. drug tolerance
- [tendency of a drug, with repeated use, to become less effective (i.e., require higher dosage) or associated with user dependence; do not use for lack of adverse reactions, as in "the subject tolerated the drug well". ( CSP )] (UMLS (CSP) C0013220) =Finding =Pharmacologic;
=insulin sensitivity/resistance;
| - 220. DRUSEN (DEGENERATIVE)
- [Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium. ( MSH )] (UMLS (ICD9CM) C0035312) =Disease or Syndrome ;
=Degeneration of retina;
|
- 205. Drug Toxicity
- [An adverse effect of a drug used therapeutically or diagnostically. ( NCI )] (UMLS (NCI) C0013221) =Injury or Poisoning =poisoning;
=dermatitis medicamentosa;
Serotonin Syndrome;
Tricyclic Antidepressant Toxicity;
Quinidine Toxicity;
Qinine Toxicity;
Aminoquinolone Toxicity | - 221. DRUSEN OF OPTIC DISC
- [Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema (elevation of the optic disk without associated INTRACRANIAL HYPERTENSION) and visual field deficits. Drusen may also occur in the retina (see RETINAL DRUSEN). (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355) ( MSH )] (UMLS (ICD9CM) C0029128) =Disease or Syndrome ;
=Optic Nerve Diseases;
|
- 206. Drug Transport
- [Any subcellular or molecular event, process, or condition involved in translocation of a drug from one site or compartment to another. (NCI) ( NCI )] (UMLS (NCI) C1154689) =Cell Function
| - 222. Dry
- (UMLS (HL7) C1550118) =Intellectual Product =Special Handling Code;
|
- 207. Drug Vehicle
- [carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. ( CSP )] (UMLS (NCI) C0042444) =Biomedical or Dental Material =DDS;
| - 223. dry
- [Keep in a dry environment ( HL7V3.0 )] (UMLS (HL7) C1550582) =Human-caused Phenomenon or Process =EntityHandling;
|
- 208. Drug withdrawal
- (UMLS (HL7) C1546942) =Idea or Concept =Event Qualification;
| - 224. Dry Creek Rancheria of Pomo Indians of California
- (UMLS (HL7) C1554294) =Population Group =NativeEntityContiguous;
|
- 209. DRUG WITHDRAWAL
- [physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation; the concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. ( CSP )] (UMLS (ICD9CM) C0152128) =Disease or Syndrome =Pharmacologic;
substance abuse related disorder | - 225. dry eye
- [ ] (UMLS (CSP) C0314719) =Sign or Symptom ;
|
- 210. Drug withdrawal syndrome in newborn
- [Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances. ( MSH )] (UMLS (ICD9CM) C0027609) =Disease or Syndrome =Infant, Newborn, Diseases;
Substance-Related Disorders | - 226. Dry Eye Syndrome
- [Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur. ( MSH )] (UMLS (NCI) C0013238) =Disease or Syndrome =Disorders of lacrimal system;
=KCS;
CONJUNCTIVAL XEROSIS;
Sjogren's syndrome;
|
- 211. Drug-Induced Aplastic Anemia
- (UMLS (NCI) C0271909) =Disease or Syndrome
| - 227. Dry Ice
- [A solid form of carbon dioxide used as a refrigerant. At temperatures above -78.5 degrees C and ambient pressure, it changes directly to a gas as it absorbs heat. ( NCI )] (UMLS (NCI) C0013239) =Inorganic Chemical
|
- 212. DRUG-INDUCED DELIRIUM
- [ ] (UMLS (ICD9CM) C0154326) =Disease or Syndrome
| - 228. dry orgasm
- [Sexual climax without the release of semen from the penis. ( NCI )] (UMLS (NCI) C0403673) =Pathologic Function
|
- 213. DRUG-INDUCED MOOD DISORD
- [ ] (UMLS (ICD9CM) C0338715) =Mental or Behavioral Dysfunction
| - 229. dry pint
- [1 [dqt_us]/2 ( HL7V3.0 )] (UMLS (HL7) C1552943) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 214. Drug-Induced Psychosis
- (UMLS (NCI) C0033937) =Mental or Behavioral Dysfunction
| - 230. dry quart
- [1 [pk_us]/8 ( HL7V3.0 )] (UMLS (HL7) C1552942) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 215. drug/alcohol abstinence
- [refraining from the use of alcohol or drugs of abuse. ( CSP )] (UMLS (CSP) C0872032) =Individual Behavior ;
=substance abuse related behavior;
| - 231. [drp]
- [A unit of volume used in pharmacy and equal to 0.05 milliliter (20 drops/ml). ( NCI )] (UMLS (NCI) C1321095) drop;
Drop Unit;
drops;
gt;
gtt;
=Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 216. DrugActionDetectedIssueCode
- [Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy ( HL7V3.0 )] (UMLS (HL7) C1699639) =Intellectual Product ;
=AdministrationDetectedIssueCode;
| |
home
